Satellos Bioscience

Forecast & Rating5 analysts currently cover Satellos Bioscience, with about 100.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $26.25, about 177.2% upside from the current price of $9.47. Price targets range from $20.00 to $40.00 — a wide spread, showing clear disagreement over just how much Satellos Bioscience can rise. For you, this means most professionals who study Satellos Bioscience closely still see room for the stock to rise. Data as of Sep 10, 2026; for reference only and not investment advice.